Literature DB >> 26321596

Performance of the Aorfix endograft in severely angulated proximal necks in the PYTHAGORAS United States clinical trial.

Mahmoud B Malas1, William D Jordan2, Michol A Cooper3, Umair Qazi3, Adam W Beck4, Michael Belkin5, William Robinson6, Mark Fillinger7.   

Abstract

OBJECTIVE: This study compared the performance of the Aorfix endograft (Lombard Medical, Oxfordshire, United Kingdom) in standard (<60°), highly angled (60°-90°), and severely angled (>90°) aortic necks in the PYTHAGORAS study and evaluated changes in neck morphology over time.
METHODS: PYTHAGORAS is a prospective nonrandomized clinical trial of the Aorfix endograft. We divided the endovascular aneurysm repair (EVAR) cohort into groups by standard, high, and severe neck angle. The primary control group was patients concurrently undergoing open repair. Mortality at 30 days, 1 year, and 2 years and 30-day freedom from Society for Vascular Surgery major adverse events for the EVAR groups was compared with the open control. Aneurysm sac change, type I and III endoleaks, graft migration, and the reintervention rate at 1 and 2 years was compared between the standard, highly, and severely angled populations. The relative risk of graft complications with a neck diameter increase >10% was also calculated. At predetermined anatomic points, the effect of oversizing on aortic diameter was evaluated by calculating oversize percentage ([1 - outer aortic diameter measured at a given time/stent graft diameter] × 100%) preoperatively and at 3 years. In addition, the average oversizing percentage at 30 days and annually at 1 to 5 years was compared with the preoperative oversizing percentage. Finally, complication rates with ≥30% vs <30% planned oversizing were compared.
RESULTS: The adverse event rate was lower for every EVAR group than the open control. In addition, the mortality rates at 30 days, 1 year, and 2 years were similar between the standard-angle (1.5%, 3.0%, 4.5%), high-angle (0.9%, 7.3%, 13.8%), and severe-angle (4.8%, 9.5%, 14.3%) EVAR groups and the open control groups (1.3, 6.6%, 10.5%). At 1 and 2 years, there was no difference in graft complications among the EVAR groups. However, with neck dilatation of >10% at 5 mm above the proximal renal and 1 mm below the distal renal, there was an increased risk of graft migration (relative risk, 4.38 [P = .01] and 4.33 [P = .002], respectively). For all predetermined anatomic points, the oversizing percentage decreased over time. The rate of oversize percentage decrease was faster at more distal aortic locations, reaching <10% at 30 days 15 mm below the renal, at 2 years 7 mm below the renal, and at 5 years 1 mm below the renal (P < .001 for all). Half the oversize percentage achieved at the index procedure remained at 3 years (Pearson correlation coefficient = 0.5). However, there was no difference in complications between the ≥30% and <30% planned oversize groups.
CONCLUSIONS: The Aorfix endograft has performed well in excluding aneurysms with standard and highly angled aortic neck anatomy.
Copyright © 2015 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26321596     DOI: 10.1016/j.jvs.2015.05.042

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  6 in total

Review 1.  A critical appraisal of endovascular stent-grafts in the management of abdominal aortic aneurysms.

Authors:  Nikolaos Schoretsanitis; Efstratios Georgakarakos; Christos Argyriou; Kiriakos Ktenidis; George S Georgiadis
Journal:  Radiol Med       Date:  2017-01-21       Impact factor: 3.469

2.  Migration of the Zenith Flex Device during Endovascular Aortic Repair of an Infrarenal Aortic Aneurysm with a Severely Angulated Neck.

Authors:  Yukihisa Ogawa; Hiroshi Nishimaki; Kiyoshi Chiba; Kenji Murakami; Yuka Sakurai; Keishi Fujiwara; Takeshi Miyairi; Yasuo Nakajima
Journal:  Ann Vasc Dis       Date:  2016-07-15

3.  Concurrent renal artery stent during endovascular infrarenal aortic aneurysm repair confers higher risk for 30-day acute renal failure.

Authors:  Besma Nejim; Isibor Arhuidese; Muhammmad Rizwan; Lana Khalil; Satinderjit Locham; Devin Zarkowsky; Philip Goodney; Mahmoud B Malas
Journal:  J Vasc Surg       Date:  2017-02-17       Impact factor: 4.268

Review 4.  Endovascular Management of Abdominal Aortic Aneurysms: the Year in Review.

Authors:  John E O'Mara; Robert M Bersin
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-08

5.  Geometric Remodeling of the Perirenal Aortic Neck at and Adjacent to the Double Sealing Ring of the Anaconda Stent-Graft After Endovascular Aneurysm Repair.

Authors:  Maaike A Koenrades; Marianne R F Bosscher; Jouke T Ubbink; Cornelis H Slump; Robert H Geelkerken
Journal:  J Endovasc Ther       Date:  2019-12       Impact factor: 3.487

Review 6.  [New developements in endovascular infrarenal aortic aneurysm treatment].

Authors:  A Maßmann; R Shayesteh-Kheslat; F Frenzel; P Fries; A Bücker
Journal:  Radiologe       Date:  2018-09       Impact factor: 0.635

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.